Andrea Guyot Consultant Microbiologist

Slides:



Advertisements
Similar presentations
Surgical Site Infection Improvement Programme Surveillance: Case studies.
Advertisements

Heather D. Mannuel, MD, MBA March 12, 2008
Linezolid-Induced Anemia in a Patient with Osteomyelitis
Infection After ACL Reconstruction H. Makhmalbaf MD Consultant Orth.& Knee Surgeon Mashhad University of Medical Sciences.
Review of Frozen Section Results and correlation with microbiology for revision joint replacement surgery Dr R Hadden BSc MBBS SpR Histopathology Derriford.
Management of Infections About Total Knee Arthroplasty Frank Ebert, M.D. Union Memorial Hospital Baltimore, MD.
Level of Evidence: Level II Clin Orthop Relat Res 2008 Journal meeting Summarized R4 黃贊文 Supervised Dr. 沈世勛 Diagnosis of Infected Total Knee.
Microbiologic Surrogates: An Industry Perspective Barry Eisenstein, MD Senior Vice President, Research and Development Cubist Pharmaceuticals Clinical.
Complications of Total Knee Arthroplasty H.Makhmalbaf MD Consultant Orthopaedic & Knee surgeon Mashad University.
Microbiology Nuts & Bolts Test Yourself – Skin & Bone Begin here.
Understanding the Importance of Prostate Health Middle aged men
Antibiotic overuse and misuse in long term care Shira Doron, MD Assistant Professor of Medicine Division of Geographic Medicine and Infectious Diseases.
Microbiological Evaluation of PJIs Survey Results Lorenzo Drago IRCCS Galeazzi Institute – University of Milan.
A RARE CASE OF SEPTIC SHOCK SECONDARY TO PRIMARY STERNOCLAVICULAR JOINT SEPTIC ARTHRITIS Dr Ehab F. Girgis & Dr Daniel S.Z.M. Boctor National Health Service,
A Retrospective Analysis of the Impact of Intramuscular Antibiotics for the Treatment of ‘Borderline’ Foot Infections - an Admission Avoidance Strategy.
NURSING CARE OF THE CHILD WITH A HEMATOLOGIC ALTERATION.
2008/12/23. Chart No Name Age/Se x DiagnosisOperation Mortality & Morbidity 陳 00 1.S/P left bipolar prosthesis with acetabular wear 2.Asthma 3.Gastroesophageal.
Introduction to Haematology! Elliot Catchpole PCMD Starting with anaemias!
Shira Doron, MD Assistant Professor of Medicine
Antibiotics Tamar Barlam Infectious Disease Director, Antimicrobial Stewardship.
Thrombotic Thrombocytopenic Purpura(TTP) Post -AllogeneicTransplant A haematological emergency: a nursing.
EDUCATIONAL WORKSHOPS 2009 CASE PRESENTATION TWO Orthopaedic graft infection Author: Savita Gossain, Heart of England Foundation Trust.
Stimulan Presentation Jak Johnston. Company Profile A small example of the products we distribute include the SAMO Trekking Knee (ITALY), Furlong and.
Management of Infections About Total Hip Arthroplasty Frank Ebert, M.D. Union Memorial Hospital Baltimore, MD.
Evaluation of a Painful Total Knee Arthroplasty Sarat Kunapuli, DO EASTERN OKLAHOMA ORTHOPEDIC CENTER.
Primary Total Hip Arthroplasty After Infection
SSI: I hear the words, but are we talking about the same thing? Safer Healthcare Now! Western Node Wendy Runge, RN, BScN, CIC Infection Prevention and.
Risk Factors Corticosteroids Existing arthritis Articular infection Infection elsewhere DM Trauma None.
Controversies in managing neonatal infections David Isaacs Children’s Hospital at Westmead Sydney Australia.
VCU DEATH AND COMPLICATIONS CONFERENCE. Introduction  Complication  Graft infection  Procedure  Femoral-femoral bypass  Primary Diagnosis  Left.
Chronic lymphocytic leukemia What is C.L.L. ? a chronic disease one particular type of lymphocyte (B-cells) accumulates. not rapidly growing and proliferating.
Evaluation of the Role for Synovial Aspiration in the Diagnosis of Aseptic Loosening After Total Knee Arthroplasty by Peter N. Chalmers, David Walton,
Cellulitis Darren Wilson Antibiotic Pharmacist Royal Bournemouth Hospital.
Neutropenic sepsis Dr Christopher Dalley Consultant Haematologist.
Perioperative Testing for Joint Infection in Patients Undergoing Revision Total Hip Arthroplasty by Mark F. Schinsky, Craig J. Della Valle, Scott M. Sporer,
CASE PRESENTATION Dr. Matu K - MBChB Dr. Ndanya S –Consultant Orthopedic Surgeon Embu Level V Hospital- Surgical Department.
BONE AND JOINT INFECTION Dr.Syed Alam Zeb Orthopaedic Unit HMC.
CURRENT CONCEPTS IN PERI-OPERATIVE TKA MANAGEMENT
Lessons Learned: Improving Surgical Antibiotic Prophylaxis Timing
Bleeding disorders Deficiency of any of the clotting factors leads to excessive bleeding Most common and important bleeding disorders are due Vitamin K.
Epidemiology, general characteristics and clinical evolution
Multiple choice questions
Tuberculosis infection complicating primary total knee arthroplasty - report of 2 unusal cases and review of the literature Dr.Sunil singh thapa Lecturer.
Surgical Site Infections:
Management of Urinary Tract Infections Renal Block
GUIDELINES FOR PROSTHETIC JOINT INFECTION CID 2013
After a Successful TAVI
Management of Urinary Tract Infections Renal Block
Thromboprophylaxis after Hip Replacement Surgery
MANAGEMENT OF ANEURYSMAL BONE CYST
M.Rao St Richard’s Hospital, Chichester West Sussex.
Is simultaneous bilateral Total Knee Arthroplasty safe in elderly patients above 70 years? A retrospective cohort study of up to 9 years follow up. Dr.
SEVERE BACK PAIN AFTER BELOW KNEE AMPUTATION- NOT ALWAYS MECHANICAL!
Peri-operative Care for Knee Arthroplasty
Radiographic follow up of hip and knee arthroplasty
Dr Savita Gossain Heart of England NHS Foundation Trust
Orthopaedic WH - Surgical Antibiotic Prophylaxis
Management of Infection and Periprosthetic Fracture in TKR
Andrea Guyot MD FRCPath MSc DTM&H DipHIC
Neutropenic sepsis case
Dr Savita Gossain Heart of England NHS Foundation Trust
Andrea Guyot Consultant Microbiologist
Risk factors for surgical site Infections
Volume 2, Issue 2, Pages (June 2016)
CASE 5.
Microbiology in Orthopaedics
West Essex Frailty Pathway: COPD
CASE 3 Dr Albert J Mifsud Consultant Public Health Microbiologist for South East London Public Health England.
Management of Periodontal Disease in Patients with HIV
Supervised by Dr Tim Bracey
Presentation transcript:

Andrea Guyot Consultant Microbiologist Educational Workshops 2013 Bone and Joint Infections UTI and prosthetic joint infections Andrea Guyot Consultant Microbiologist

77 y female patient: May 2011 L TKR insertion 1995 right TKR 3.5.2011 left TKR ASA3, BMI 33, MRSA neg comorbidities: Leg ulcers on shins with recurrent cellulitis Recurrent UTIs (last UTI in April 2011 on pre-assessment with fully sensitive E. coli) Chronic anaemia (Hb 10, iron 7)

What are known risk factors for prosthetic joint infections?

Facilitator Slide Risk factors for PJI (Pulido et al Clin Orth Rel Res 2008;466:1710, Matthews et al. BMJ 2009; 338: 1378) ASA>2 BMI >35 Diabetes TKA Bilateral arthroplasty Duration of procedure >90min Haematoma and oozing >5d

20.11.2011 Admission for vertigo Diagnosis of benign paroxymal positional vertigo treated with cinnarizine Urine: 1450 WBC (culture isolates identified by MaldiTOF): Klebsiella res amoxicilin only plus Enterobacter aerogenes res: Augmentin, cefalexin sens: cipro, trimethroprim, gentamicin, meropenem, cefpodoxime Blood: iron deficiency anaemia with iron 3 umol/l and transferrin 2.26g/l Platelets 320, WBC 9.9, Hb 8.9, CRP 49

Home discharge Discharge home on trimethroprim (to be taken until 26.11.2011) On 13.12.2011 readmission for swollen hot L TKR WBC 10, CRP 203, ESR 21, Hb 7.5, platelets 23 MSU: 94 WBC; Enterobacter aerogenes res: Augmentin, cefalexin sens: cipro, gent, cefpodoxime, trimethroprim

13.12.2011 Synovial fluid 3720 WBC, 73% PMN Citrobacter koseri (identified by MaldiTOF) res: Augmentin, cefuroxime sens: cipro, gent , cefpodoxime

What are the sensitivities of investigations on synovial fluid?

Facilitator Slide Synovial fluid investigations for the diagnosis of PJI Sensitivity specificity reference Gram 0.36 0.99 J Bone Joint Surg Am. 1999 ;81:672-83 culture 0.8-0.9 JAMA 1990:264:1009 Synovial cell count >1590 WBC/ul 0.89 0.91 J BoneJoint Surg Br 2013; 95:554-7 Synovial differential count PMN>65% 0.90 0.87

Risk of UTI for PJI Maderazo E et al Risk of UTI for PJI Maderazo E et al. Late infections of total joint prosthesis. Clin. Orthop Relat Res 1988;229:131-142 Incidence of PJI=1% Risk for haematogenous seeding 1:5= 0.2% Risk for seeding from UTI = 13% of 0.2%=0.026%= 26:100000 = approximately 1:4000 arthroplasties get infected by haematogenous seeding from UTI

15.12.2011 1st stage of revision Removal of TKR and implantation of Vancogenx spacer with Palacos R&G (gentamicin) cement on prophylactic dose of teicoplanin 600mg and 120mg gentamicin Meropenem 1g tds started postop 5 periprosthetic tissues grow Citrobacter kosei sens: meropenem, gentamicin, ciprofloxacin

How many periprosthetic tissues are required for DIAGNOSIS of PJI and what is the performance?

Facilitator Slide

Which antibiotic would you choose for citrobacter?

Facilitator Slide Antimicrobial therapy for Citrobacter

16.12.2011 post-op Platelets 13, Hb 5.6, prothrombin time 15 sec, PT ratio 1.3 Haematological diagnosis: Thrombotic thrombocytopenic purpura Transferred to a specialist hospital for Rituximab and plasma exchange The features in the blood tests just prior to Christmas 2011 are absolutely classic with clear evidence of haemolysis, a grossly raised LDH of 1545 iu/L and no discernible ADAMS TS13 evident in her peripheral bloods. The low platelet count was because of the inability of the enzyme ADAMS TS13 to cut von Willebrand’s factor off her endothelial cells and therefore platelets were deposited in the vessel as a consequence. The most important thing in a patient like this is that you do not receive a platelet transfusion, which has been associated with fatal thrombotic stroke. Fortunately she was transferred to the specialist hospital for plasmaphoresis with FFP, which acts as a source of the missing enzyme ADAMS TS13 and also Rituximab therapy to destroy the B lymphocytes which produce the antibody in the first place.

25.1.2012 Return from specialist hospital on meropenem 1g tds: MRSA in nose, not in groin Mupirocin and chlorhexidine washes prescribed CRP 7.8, WBC 8, HB 10.5, platelets 300 going home on 26.1. on oral ciprofloxacin 750mg bd until 10.3.2012

How long should antibiotics be given between 2 stages of revision?

Facilitator Slide

26.4.2012 Preassessment: MRSA neg, CRP 4, ESR 6, WBC 3.4, platelets 240, Hb 12.4 MSU 64 WBC, no growth

2.5.2012 2nd stage revision arthroplasty on flucloxacillin and gentamicin Joint fluid and tissues on enrichment culture: no growth

Follow up Discharge home 21.5.2012 ESR 21, CRP 5.4, WBC 3.4, platelets 208 Platelets 360, Hb 10.9 Follow up on 12.3.2013 (at 10 months after 2nd stage) No sinus formation CRP <4, ESR 16, WBC 5.7, Hb 11.9 Oxford score 22 (max=50, good revision outcome >30) with pain score 1 (=mild) ROM 120 C with lateral ligament laxity Xray: no loosening